C6orf10 Polyclonal Antibody, PE-Cy5.5 Conjugated
Applications
Reactivity
Predicted Reactivity
| Overview | |
| Catalog # | bs-9531R-PE-Cy5.5-100uL |
| Product Name | C6orf10 Polyclonal Antibody, PE-Cy5.5 Conjugated |
| Applications |
WB
|
| Reactivity | Mouse |
| Predicted Reactivity | Human |
| Specifications | |
| Conjugation | PE-Cy5.5 |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human TSBP |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1ug/ul |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 9646 |
| Synonyms | C6orf10; CF010_HUMAN; Chromosome 6 open reading frame 10; Testis specic basic protein; TSBP; Uncharacterized protein C6orf10. |
| Background | Making up nearly 6% of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposes an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf10 gene product has been provisionally designated C6orf10 pending further characterization. |
| Application Dilution | |
| WB | 1:300-5000 |
Frequently asked questions
Which applications is C6orf10 Polyclonal Antibody, PE-Cy5.5 Conjugated (BS-9531R-PE-CY5-5) validated for, and at what dilution?
BS-9531R-PE-CY5-5 is validated for WB (1:300-5000). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does C6orf10 Polyclonal Antibody, PE-Cy5.5 Conjugated (BS-9531R-PE-CY5-5) react with?
Tested reactivity: Mouse. Predicted reactivity (expected from sequence homology but not yet tested): Human.
How should BS-9531R-PE-CY5-5 be stored?
Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. Storage buffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise C6orf10 Polyclonal Antibody, PE-Cy5.5 Conjugated (BS-9531R-PE-CY5-5)?
KLH conjugated synthetic peptide derived from human TSBP
What are the excitation and emission wavelengths of the PE-Cy5.5 conjugate (BS-9531R-PE-CY5-5)?
PE-Cy5.5 on BS-9531R-PE-CY5-5: excitation / emission 488nm/694nm.